Johannes Breedt

Summary

Publications

  1. pmc Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam
    Johannes Breedt
    Eugene Marais Hospital, Les Marais, Pretoria, Republic of South Africa
    Antimicrob Agents Chemother 49:4658-66. 2005
  2. doi request reprint Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
    Martin E Stryjewski
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Clin Infect Dis 46:1683-93. 2008
  3. doi request reprint Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study
    I Florescu
    Emergency Clinical Hospital, Bucharest, Romania
    J Antimicrob Chemother 62:i17-28. 2008

Collaborators

  • Martin E Stryjewski
  • Karl Weiss
  • M Bassetti
  • I Florescu
  • Thomas Adam Kasper
  • Luis Ernesto Jauregi Peredo
  • Michael J Patzakis
  • William J Flynn
  • Latha Srinath
  • G Fichev
  • C A Cooper
  • Guglia Ion Dumitru
  • Marek Ostrowski
  • Alberto Bedulatti Cardosa
  • Diana Brasil Pedral Sampaio
  • Antonio Policarpo Ludvik
  • John F Reinhardt
  • Maria del Rayo Morfin Otero
  • Salah Bibi
  • Krzysztof Kolomecki
  • Jaime Alejandro Labarca
  • E J Ellis-Grosse
  • J H Cansen van Rensburg
  • Harmohinder Gogia
  • Clovis Arns Da Cunha
  • Helen Giamarellou
  • Manjari Joshi
  • K Dean Gubler
  • T Babinchak
  • Christian G Schrock
  • Milagros Pagaduan Reyes
  • H Gandjini
  • Markian R Bochan
  • Fredrique Jacobs
  • A Razbadauskas
  • Maria Eugenia Valias Didier
  • Donald R Graham
  • Ali El Solh
  • M Bochan
  • Robert L Penn
  • Jose Prieto
  • Priscilla Siosan
  • M Beuran
  • Carlos Lovesio
  • Claudia Gabriela Rodriguez
  • Petre Jacob Calistru
  • R Dimov
  • Arnold Lentnek
  • Mark Harrison
  • John E Mazuski
  • Antonio Tarcisiode Faria Freire
  • Jack Cade
  • Miguel Sanchez
  • N Dartois
  • G Dukart
  • Maria Eugenia Oliva
  • Zilvinas Endzinas

Detail Information

Publications3

  1. pmc Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam
    Johannes Breedt
    Eugene Marais Hospital, Les Marais, Pretoria, Republic of South Africa
    Antimicrob Agents Chemother 49:4658-66. 2005
    ..Tigecycline was shown to be safe and effective for the treatment of complicated skin and skin structure infections...
  2. doi request reprint Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
    Martin E Stryjewski
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Clin Infect Dis 46:1683-93. 2008
    ..Telavancin is an investigational, rapidly bactericidal lipoglycopeptide with a multifunctional mechanism of action...
  3. doi request reprint Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study
    I Florescu
    Emergency Clinical Hospital, Bucharest, Romania
    J Antimicrob Chemother 62:i17-28. 2008
    ..Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are causing serious nosocomial infections. Tigecycline was evaluated in hospitalized patients with MRSA or VRE infection...